Clinical features, tumor biology and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical features, tumor biology and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 28, Issue 12, Pages 1555-1573
Publisher
Springer Nature
Online
2015-11-06
DOI
10.1038/modpathol.2015.118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffuse Large B-cell Lymphomas of Immunoblastic Type Are a Major Reservoir for MYC-IGH Translocations
- (2015) Heike Horn et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MYC Cytogenetic Status Correlates With Expression and Has Prognostic Significance in Patients With MYC/BCL2 Protein Double-positive Diffuse Large B-cell Lymphoma
- (2015) Xuan Julia Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Genetic lesions in diffuse large B-cell lymphomas
- (2015) M. Testoni et al. ANNALS OF ONCOLOGY
- Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
- (2015) H Horn et al. LEUKEMIA
- Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions
- (2015) Chi Young Ok et al. MODERN PATHOLOGY
- Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma
- (2015) Jiayu Chen et al. Oncotarget
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
- (2014) J. Iqbal et al. BLOOD
- A clinician's guide to double hit lymphomas
- (2014) Chan Yoon Cheah et al. BRITISH JOURNAL OF HAEMATOLOGY
- MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
- (2014) Anamarija M. Perry et al. BRITISH JOURNAL OF HAEMATOLOGY
- MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
- (2013) Z. Y. Xu-Monette et al. BLOOD
- MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?
- (2013) C. Thieblemont et al. BLOOD
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification
- (2013) G. Ott et al. BLOOD
- Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation
- (2013) C. Huang et al. BLOOD
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2013) S. Hu et al. BLOOD
- Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
- (2013) S. M. Aukema et al. HAEMATOLOGICA
- MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) A. Valera et al. HAEMATOLOGICA
- SMAD regulatory networks construct a balanced immune system
- (2013) Nidhi Malhotra et al. IMMUNOLOGY
- Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
- (2013) Alexandar Tzankov et al. MODERN PATHOLOGY
- High Levels of Nuclear MYC Protein Predict the Presence of MYC Rearrangement in Diffuse Large B-cell Lymphoma
- (2012) Tina Marie Green et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
- (2012) M. Chesi et al. BLOOD
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) Z. Y. Xu-Monette et al. BLOOD
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
- (2012) Zuqin Nie et al. CELL
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
- (2012) C. Visco et al. HAEMATOLOGICA
- Growing Importance of MYC/BCL2 Immunohistochemistry in Diffuse Large B-Cell Lymphomas
- (2012) Michael Pfreundschuh JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- BCL6 positively regulates AID and germinal center gene expression via repression of miR-155
- (2012) Katia Basso et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
- (2012) Dinis Pedro Calado et al. NATURE IMMUNOLOGY
- Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFβ and ATM pathways
- (2012) Minli Wang et al. NUCLEIC ACIDS RESEARCH
- Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
- (2012) Michael J. Kluk et al. PLoS One
- Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma
- (2012) Kanutte Huse et al. PLoS One
- MicroRNA signatures in B-cell lymphomas
- (2012) L Di Lisio et al. Blood Cancer Journal
- Prognostic significance ofMYC,BCL2, andBCL6rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
- (2011) Nalan Akyurek et al. CANCER
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas
- (2011) Gustavo Tapia et al. HISTOPATHOLOGY
- MicroRNA-21 Limits In Vivo Immune Response-Mediated Activation of the IL-12/IFN- Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity
- (2011) T. X. Lu et al. JOURNAL OF IMMUNOLOGY
- Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC
- (2011) T Holien et al. LEUKEMIA
- MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4
- (2011) K Schramedei et al. ONCOGENE
- Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
- (2010) Sharon Barrans et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
- (2009) N. A. Johnson et al. BLOOD
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome
- (2009) Maria Grazia Tibiletti et al. HUMAN PATHOLOGY
- Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment
- (2009) E C Obermann et al. JOURNAL OF CLINICAL PATHOLOGY
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation
- (2008) Yair Dorsett et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started